We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futuragene | LSE:FGN | London | Ordinary Share | GB0031791782 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 89.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMFGN RNS Number : 2196P Futuragene PLC 12 July 2010 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO THE SAME WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION 12 July 2010 FuturaGene plc ("FuturaGene" or "the Company") Announcement of Court confirmation of Reduction of Capital, Scheme becoming effective and cancellation of admission to trading on AIM In relation to the recommended all cash offer by Suzano Trading Limited, a wholly owned subsidiary of Suzano Papel e Celulose S.A. for FuturaGene (which was approved by FuturaGene shareholders on 21 June 2010 and sanctioned by the Court on 8 July 2010), FuturaGene is pleased to announce that the Court confirmed the Reduction of Capital today and that the Court's approval will be delivered to the Registrar of Companies (along with a statement of capital) and registered by the Registrar tomorrow. Accordingly, once they have been registered the Scheme will become effective in accordance with its terms. In an update to the published timetable, the Company has requested that admission of the FuturaGene Shares to trading on AIM be cancelled with effect from 7.00 a.m. on 14 July 2010 and that the FuturaGene Shares remain suspended pending the cancellation. The consideration due to Scheme Shareholders and holders of Warrants will be sent no later than 14 days after the Effective Date. Terms defined in the scheme document sent to FuturaGene Shareholders on 28 May 2010 have the same meanings in this announcement. All references to times in this announcement are to London time unless otherwise stated. For further information, please contact: FuturaGene Plc Mark Pritchard, Chairman +44 (0) 7802 827 846 Stanley Hirsch, CEO +972 544 562 724 Evolution Securities Neil Elliot +44 (0) 20 7071 4300 College Hill +44 (0) 20 7457 2020 Adrian Duffield/Carl Franklin/Rozi Morris Suzano Papel e Celulose André Dorf +55 11 3503 9240 BNP Paribas (financial adviser to Suzano Bidco and Suzano Papel e Celulose) Claude Herskovits (London) +44 (0) 20 7595 6709 Leandro Almeida (São Paulo) +55 11 3841 3626 Tulchan Communications (PR adviser to Suzano Bidco) Andrew Grant + 44 (0) 20 7427 1554 This information is provided by RNS The company news service from the London Stock Exchange END MSCBUGDRIDBBGGD
1 Year Futuragene Chart |
1 Month Futuragene Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions